- Home
- ESNT vs TECH Comparison
ESNT vs TECH Comparison
Compare ESNT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESNT
- TECH
- Stock Information
- Founded
- ESNT 2008
- TECH 1976
- Country
- ESNT Bermuda
- TECH United States
- Employees
- ESNT N/A
- TECH N/A
- Industry
- ESNT Property-Casualty Insurers
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESNT Finance
- TECH Health Care
- Exchange
- ESNT Nasdaq
- TECH Nasdaq
- Market Cap
- ESNT N/A
- TECH 8.0B
- IPO Year
- ESNT 2013
- TECH 1989
- Fundamental
- Price
- ESNT $56.75
- TECH $53.29
- Analyst Decision
- ESNT Buy
- TECH Buy
- Analyst Count
- ESNT 7
- TECH 8
- Target Price
- ESNT $61.71
- TECH $81.14
- AVG Volume (30 Days)
- ESNT 749.7K
- TECH 2.2M
- Earning Date
- ESNT 05-09-2025
- TECH 05-07-2025
- Dividend Yield
- ESNT 2.24%
- TECH 0.65%
- EPS Growth
- ESNT 5.38
- TECH N/A
- EPS
- ESNT 6.85
- TECH 0.98
- Revenue
- ESNT $1,242,904,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- ESNT $4.19
- TECH $8.19
- Revenue Next Year
- ESNT $4.79
- TECH $8.85
- P/E Ratio
- ESNT $8.09
- TECH $49.94
- Revenue Growth
- ESNT 12.00
- TECH 4.46
- 52 Week Low
- ESNT $51.61
- TECH $46.44
- 52 Week High
- ESNT $65.33
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- ESNT 54.45
- TECH 37.52
- Support Level
- ESNT $53.31
- TECH $46.01
- Resistance Level
- ESNT $56.58
- TECH $53.00
- Average True Range (ATR)
- ESNT 1.89
- TECH 3.23
- MACD
- ESNT 0.08
- TECH -0.18
- Stochastic Oscillator
- ESNT 79.37
- TECH 24.31
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.